ClinicalTrials.gg
RecruitingNCT06633146Updated Feb 28, 2025

Stroke Rehabilitation Utilizing Therapeutical Methods Designed for Nature Environments

An interventional study of Therapies in nature in Stroke, Stress, Psychological and Post Traumatic Stress Disorder, sponsored by Joint Authority for Päijät-Häme Social and Health Care. Recruiting at 1 site in Finland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-28.

Sponsored by Joint Authority for Päijät-Häme Social and Health Care · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Outpatient participants with a recent stroke diagnoses receive complimentary rehabilitation. The nature interventions include ergo- and physiotherapeutic and neurocognitive tasks with the support of an psychotherapeutic frame designed to be performed in a nature environment.

Read the detailed description

Patients with an acute stroke are recruited to the study when signing out from the acute hospital care services. The patients are selected randomly into two groups: intervention and control groups in proportions 1:1. During the four-week study period the partipants in the control group are encouraged to maintain light physical activity 1 to 3 times per week with or without company. The research worker contacts the participants every week. In the nature group the research worker organises individual nature visits in the nearby nature twice a week and encourages the participants to go outdoors with a close-one once a week. All interventional contacts in the nature group are performed in a ecopsychotherapeutical frame consisting of ergo- and physiotherapeutic and neurocognitive tasks.

02

Conditions studied

  • Stroke
  • Stress, Psychological
  • Post Traumatic Stress Disorder
  • Depression, Anxiety
  • Loneliness

Keywords

  • stroke
  • rehabilitation
  • social support
  • cognitive functions
  • activity
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 40 is below the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Joint Authority for Päijät-Häme Social and Health Care is the lead sponsor of 19 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Acute stroke

Exclusion criteria

Exclusion Criteria:

  • Traumatic intracranial bleeding without stroke
  • A malign, aggressive disease
  • Severe aphasia or incapable of independent decision making
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Nature intervention group

    Participants take part in therapeutic individual and group sessions organised in nearby nature by the research worker.

    Behavioral: Therapies in nature

  • No intervention
    Control group

    Participants do not participate in organised sessions but are encouraged to maintain physical activity and social life.

Interventions

  • BehavioralTherapies in nature

    Therapeutic tasks in nature specifically designed for the study

06

What researchers measure

Primary outcomes

  1. The effect of nature interventions on PROMIS questionnaire

    Self-assessed quality of life assessed by a PROMIS (patient-reported outcomes measurement information system) questionnaire. Time points measured wk 0 and wk 4, efficacy evaluated on the basis of the difference between these time points. An increase in the obtained score is considered a positive effect.

    Time frame: 4 weeks

Secondary outcomes

  1. The effect of nature interventions on moods assessed by GAD7

    Evaluation of anxiety scales by a GAD7 (generalised anxiety disorder 7) interview, the score of the questionnaire (0-21 points) is evaluated wk 0 and wk 4. A decrease in the total score is considered as a positive effect on moods.

    Time frame: 4 weeks

  2. The effect of nature-based intervention on neurocognitive functions in COMET questionnaire

    Assessment of the efficacy of nature-based neuropsychological tasks on neurocognitive functions by a cognitive test COMET (cognitive method) -questionnaire. The total score is evaluated wk0 and wk4. An increase in the total score is considered a positive effect.

    Time frame: 4 wk

Other outcomes

  1. The effect of nature interventions on functional ability assessed by a validated questionnaire WHODAS

    Self-assessed functional ability in everyday life with a validated questionnaire WHODAS (WHO disability assessment scale). The total scores are evaluated wk0 and wk4. An increase in the total score is considered a positive effect.

    Time frame: 4 weeks

  2. The effect of nature interventions on microbiome

    Microbiological analyses from skin flake and stool samples

    Time frame: 4 weeks

  3. The effect of nature interventions on the activity of autonomic nervous system

    The evaluation of the state of the autonomic nervous system by heart rate variability by a portable device.

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Salonen K, Hyvonen K, Paakkolanvaara JV, Korpela K. Flow With Nature Treatment for Depression: Participants' Experiences. Front Psychol. 2022 Jan 5;12:768372. doi: 10.3389/fpsyg.2021.768372. eCollection 2021. PubMed 35069344 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06633146
Lead sponsor
Joint Authority for Päijät-Häme Social and Health Care
Collaborators
University of Helsinki, University of Jyvaskyla, Tampere University
Responsible party
Sponsor
First posted
Oct 9, 2024
Start date
Jun 1, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Feb 28, 2025

Study contacts

Hanna Haveri, MD PhD
Contact
hanna.haveri@paijatha.fi
+358 3 81911
Marja Mikkelsson, Prof
Contact
marja.mikkelsson@paijatha.fi
+358 3 81911
Hanna Haveri, MD PhD
principal investigator · Wellbeing Services County of Paijat-Hame

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion